Unresolved disorder model. using A ATOM 21 CG AHIS 4 9.176 2.163 6.947 0.50 36.57 C Unresolved disorder model. using A ATOM 22 ND1AHIS 4 8.368 2.962 6.171 0.50 39.28 N Unresolved disorder model. using A ATOM 23 CD2AHIS 4 10.342 2.831 7.165 0.50 38.38 C Unresolved disorder model. using A ATOM 24 CE1AHIS 4 9.051 4.065 5.905 0.50 38.19 C Unresolved disorder model. using A ATOM 25 NE2AHIS 4 10.255 4.018 6.505 0.50 34.50 N Unresolved disorder model. using A ATOM 181 CG1AILE 22 4.317 5.283 25.085 0.50 10.87 C Unresolved disorder model. using A ATOM 182 CG1BILE 22 4.254 5.432 25.019 0.50 9.58 C Unresolved disorder model. using A ATOM 184 CD1AILE 22 3.400 6.474 24.755 0.50 12.55 C Unresolved disorder model. using A ATOM 185 CD1BILE 22 4.827 6.082 26.202 0.50 17.37 C Unresolved disorder model. using A ATOM 273 CB AASP 34 -8.475 -11.422 33.732 0.50 8.19 C Unresolved disorder model. using A ATOM 274 CB BASP 34 -8.430 -11.564 33.672 0.50 10.90 C Unresolved disorder model. using A ATOM 275 CG AASP 34 -8.820 -12.373 34.862 0.50 8.59 C Unresolved disorder model. using A ATOM 276 CG BASP 34 -8.537 -12.859 34.497 0.50 9.53 C Unresolved disorder model. using A ATOM 277 OD1AASP 34 -7.859 -12.764 35.548 0.50 13.93 O Unresolved disorder model. using A ATOM 278 OD1BASP 34 -9.020 -12.712 35.643 0.50 14.77 O Unresolved disorder model. using A ATOM 279 OD2AASP 34 -9.942 -12.814 35.052 0.50 10.55 O Unresolved disorder model. using A ATOM 280 OD2BASP 34 -8.149 -13.903 34.055 0.50 13.66 O Unresolved disorder model. using A ATOM 364 CB ALYS 45 -23.244 7.214 31.380 0.50 15.36 C Unresolved disorder model. using A ATOM 365 CB BLYS 45 -23.170 7.179 31.267 0.50 19.52 C Unresolved disorder model. using A ATOM 366 CG ALYS 45 -22.728 8.185 32.451 0.50 17.93 C Unresolved disorder model. using A ATOM 367 CG BLYS 45 -24.236 8.134 31.649 0.50 26.28 C Unresolved disorder model. using A ATOM 368 CD ALYS 45 -23.960 8.736 33.176 0.50 25.49 C Unresolved disorder model. using A ATOM 369 CD BLYS 45 -24.698 9.045 30.559 0.50 27.59 C Unresolved disorder model. using A ATOM 370 CE ALYS 45 -25.004 9.322 32.174 0.50 31.98 C Unresolved disorder model. using A ATOM 371 CE BLYS 45 -26.126 9.470 30.432 0.50 26.58 C Unresolved disorder model. using A ATOM 372 NZ ALYS 45 -25.748 10.531 32.552 0.50 37.46 N Unresolved disorder model. using A ATOM 373 NZ BLYS 45 -26.903 9.143 31.696 0.50 35.92 N Unresolved disorder model. using A ATOM 514 CB AHIS 64 -0.318 -2.042 8.835 0.50 12.10 C Unresolved disorder model. using A ATOM 515 CB BHIS 64 -0.603 -1.671 8.588 0.50 7.87 C Unresolved disorder model. using A ATOM 516 CG AHIS 64 -0.352 -0.635 8.862 0.50 15.35 C Unresolved disorder model. using A ATOM 517 CG BHIS 64 0.705 -0.994 8.454 0.50 8.46 C Unresolved disorder model. using A ATOM 518 ND1AHIS 64 -1.368 0.207 9.359 0.50 24.71 N Unresolved disorder model. using A ATOM 519 ND1BHIS 64 1.239 0.340 7.822 0.50 18.67 N Unresolved disorder model. using A ATOM 520 CD2AHIS 64 0.585 0.102 8.254 0.50 13.50 C Unresolved disorder model. using A ATOM 521 CD2BHIS 64 1.919 -1.625 8.572 0.50 8.13 C Unresolved disorder model. using A ATOM 522 CE1AHIS 64 -0.823 1.412 8.975 0.50 25.46 C Unresolved disorder model. using A ATOM 523 CE1BHIS 64 2.355 0.333 7.995 0.50 12.49 C Unresolved disorder model. using A ATOM 524 NE2AHIS 64 0.324 1.403 8.351 0.50 21.50 N Unresolved disorder model. using A ATOM 525 NE2BHIS 64 2.978 -0.761 8.421 0.50 11.87 N Unresolved disorder model. using A ATOM 612 CB AASP 75 -21.961 17.116 14.551 0.50 16.72 C Unresolved disorder model. using A ATOM 613 CB BASP 75 -21.465 16.388 15.203 0.50 21.05 C Unresolved disorder model. using A ATOM 614 CG AASP 75 -22.637 16.617 15.815 0.50 13.66 C Unresolved disorder model. using A ATOM 615 CG BASP 75 -20.554 16.013 16.396 0.50 19.60 C Unresolved disorder model. using A ATOM 616 OD1AASP 75 -23.494 17.286 16.394 0.50 22.38 O Unresolved disorder model. using A ATOM 617 OD1BASP 75 -19.629 15.100 16.477 0.50 16.06 O Unresolved disorder model. using A ATOM 618 OD2AASP 75 -22.316 15.487 16.217 0.50 16.07 O Unresolved disorder model. using A ATOM 619 OD2BASP 75 -20.756 16.802 17.321 0.50 37.39 O Unresolved disorder model. using A ATOM 685 CB AASP 85 -16.072 13.144 29.772 0.50 18.34 C Unresolved disorder model. using A ATOM 686 CB BASP 85 -15.685 12.859 29.625 0.50 16.10 C Unresolved disorder model. using A ATOM 687 CG AASP 85 -16.177 12.574 31.183 0.50 16.40 C Unresolved disorder model. using A ATOM 688 CG BASP 85 -15.820 14.243 30.069 0.50 13.84 C Unresolved disorder model. using A ATOM 689 OD1AASP 85 -17.108 11.743 31.333 0.50 22.38 O Unresolved disorder model. using A ATOM 690 OD1BASP 85 -15.032 14.717 30.980 0.50 14.99 O Unresolved disorder model. using A ATOM 691 OD2AASP 85 -15.404 12.934 32.147 0.50 26.83 O Unresolved disorder model. using A ATOM 692 OD2BASP 85 -16.797 14.958 29.562 0.50 16.99 O Unresolved disorder model. using A ATOM 914 CE ALYS 112 -12.300 -17.332 21.140 0.50 20.63 C Unresolved disorder model. using A ATOM 915 CE BLYS 112 -12.805 -17.470 21.397 0.50 23.73 C Unresolved disorder model. using A ATOM 916 NZ ALYS 112 -13.100 -18.622 21.225 0.50 7.16 N Unresolved disorder model. using A ATOM 917 NZ BLYS 112 -11.833 -17.205 20.258 0.50 44.19 N Unresolved disorder model. using A ATOM 1059 CB AASP 129 -8.973 17.717 13.678 0.50 9.14 C Unresolved disorder model. using A ATOM 1060 CB BASP 129 -8.083 17.957 14.068 0.50 12.41 C Unresolved disorder model. using A ATOM 1061 CG AASP 129 -7.613 18.247 13.860 0.50 7.97 C Unresolved disorder model. using A ATOM 1062 CG BASP 129 -6.662 18.419 14.292 0.50 10.44 C Unresolved disorder model. using A ATOM 1063 OD1AASP 129 -6.967 18.097 14.999 0.50 9.67 O Unresolved disorder model. using A ATOM 1064 OD1BASP 129 -6.395 19.610 14.375 0.50 14.19 O Unresolved disorder model. using A ATOM 1065 OD2AASP 129 -7.020 18.842 12.983 0.50 11.93 O Unresolved disorder model. using A ATOM 1066 OD2BASP 129 -5.720 17.627 14.576 0.50 10.73 O Unresolved disorder model. using A ATOM 1640 CB ACYS 205 -4.334 9.161 22.777 0.60 7.39 C Unresolved disorder model. using A ATOM 1641 CB BCYS 205 -4.791 8.936 22.633 0.40 7.11 C Unresolved disorder model. using A ATOM 1642 SG ACYS 205 -2.672 9.760 22.478 0.60 7.35 S Unresolved disorder model. using A ATOM 1643 SG BCYS 205 -3.218 9.235 21.802 0.40 8.09 S Unresolved disorder model. using A ATOM 1751 CB ASER 219 -14.716 -20.086 6.560 0.50 12.86 C Unresolved disorder model. using A ATOM 1752 CB BSER 219 -14.912 -20.098 6.431 0.50 11.43 C Unresolved disorder model. using A ATOM 1753 OG ASER 219 -15.533 -20.663 5.619 0.50 18.20 O Unresolved disorder model. using A ATOM 1754 OG BSER 219 -13.580 -20.488 6.263 0.50 11.07 O Unresolved disorder model. using A ATOM 1785 CG ALEU 223 -10.516 -18.525 3.386 0.50 18.10 C Unresolved disorder model. using A ATOM 1786 CG BLEU 223 -10.785 -18.402 3.860 0.50 11.61 C Unresolved disorder model. using A ATOM 1787 CD1ALEU 223 -9.023 -18.861 3.161 0.50 26.04 C Unresolved disorder model. using A ATOM 1788 CD1BLEU 223 -11.610 -19.561 3.255 0.50 13.08 C Unresolved disorder model. using A ATOM 1789 CD2ALEU 223 -10.815 -18.714 4.853 0.50 27.15 C Unresolved disorder model. using A ATOM 1790 CD2BLEU 223 -9.340 -18.885 3.902 0.50 11.72 C Unresolved disorder model. using A ATOM 1912 CB AGLU 238 4.412 -10.255 2.092 0.50 17.78 C Unresolved disorder model. using A ATOM 1913 CB BGLU 238 4.445 -10.293 2.105 0.50 19.79 C Unresolved disorder model. using A ATOM 1914 CG AGLU 238 4.600 -10.751 3.517 0.50 15.26 C Unresolved disorder model. using A ATOM 1915 CG BGLU 238 5.475 -9.502 1.408 0.50 25.90 C Unresolved disorder model. using A ATOM 1916 CD AGLU 238 5.292 -12.094 3.598 0.50 18.67 C Unresolved disorder model. using A ATOM 1917 CD BGLU 238 5.798 -8.127 1.974 0.50 31.00 C Unresolved disorder model. using A ATOM 1918 OE1AGLU 238 4.588 -12.966 4.077 0.50 18.20 O Unresolved disorder model. using A ATOM 1919 OE1BGLU 238 5.818 -8.123 3.219 0.50 48.22 O Unresolved disorder model. using A ATOM 1920 OE2AGLU 238 6.469 -12.253 3.293 0.50 20.38 O Unresolved disorder model. using A ATOM 1921 OE2BGLU 238 5.903 -7.119 1.253 0.50 41.19 O Unresolved disorder model. using A ATOM 2027 CG ALYS 251 2.222 -1.713 32.873 0.50 11.70 C Unresolved disorder model. using A ATOM 2028 CG BLYS 251 2.202 -2.371 33.068 0.50 11.93 C Unresolved disorder model. using A ATOM 2029 CD ALYS 251 3.496 -2.094 33.550 0.50 17.25 C Unresolved disorder model. using A ATOM 2030 CD BLYS 251 3.229 -1.404 32.453 0.50 10.20 C Unresolved disorder model. using A ATOM 2031 CE ALYS 251 4.547 -2.528 32.658 0.50 16.38 C Unresolved disorder model. using A ATOM 2032 CE BLYS 251 4.365 -2.131 31.853 0.50 15.54 C Unresolved disorder model. using A ATOM 2033 NZ ALYS 251 5.889 -2.551 33.279 0.50 29.83 N Unresolved disorder model. using A ATOM 2034 NZ BLYS 251 5.344 -1.295 31.163 0.50 15.87 N Unresolved disorder model. using A ATOM 2076 CG ALYS 256 -13.809 -0.250 35.442 0.65 10.72 C Unresolved disorder model. using A ATOM 2077 CG BLYS 256 -13.679 -0.284 35.395 0.35 12.38 C Unresolved disorder model. using A ATOM 2078 CD ALYS 256 -13.851 -0.993 36.788 0.65 8.65 C Unresolved disorder model. using A ATOM 2079 CD BLYS 256 -13.806 1.095 35.928 0.35 23.78 C Unresolved disorder model. using A ATOM 2080 CE ALYS 256 -13.184 -0.151 37.917 0.65 11.35 C Unresolved disorder model. using A ATOM 2081 CE BLYS 256 -13.358 1.591 37.296 0.35 35.20 C Unresolved disorder model. using A ATOM 2082 NZ ALYS 256 -13.341 -0.791 39.236 0.65 10.42 N Unresolved disorder model. using A ATOM 2083 NZ BLYS 256 -14.008 2.846 37.840 0.35 27.98 N Unresolved disorder model. using A ATOM 2110 CB ALYS 260 -24.615 -7.270 36.860 0.50 36.18 C Unresolved disorder model. using A ATOM 2111 CB BLYS 260 -24.613 -7.357 36.886 0.50 35.96 C Unresolved disorder model. using A ATOM 2112 CG ALYS 260 -24.416 -6.008 37.660 0.50 35.59 C Unresolved disorder model. using A ATOM 2113 CG BLYS 260 -24.155 -7.419 38.338 0.50 38.47 C Unresolved disorder model. using A ATOM 2114 CD ALYS 260 -25.258 -4.811 37.333 0.50 33.91 C Unresolved disorder model. using A ATOM 2115 CD BLYS 260 -22.652 -7.148 38.344 0.50 41.66 C Unresolved disorder model. using A ATOM 2116 CE ALYS 260 -26.061 -4.548 38.634 0.50 35.45 C Unresolved disorder model. using A ATOM 2117 CE BLYS 260 -22.106 -7.086 39.748 0.50 41.55 C Unresolved disorder model. using A ATOM 2118 NZ ALYS 260 -26.886 -3.350 38.749 0.50 45.02 N Unresolved disorder model. using A ATOM 2119 NZ BLYS 260 -23.135 -6.603 40.725 0.50 45.18 N 1